Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

My AVN Article Published

Download as pdf or txt
Download as pdf or txt
You are on page 1of 9

Chief Editor

Dr. A. Singaraj, M.A., M.Phil., Ph.D.


Managing Editor
Mrs.M.Josephin Immaculate Ruba
EDITORIAL ADVISORS
1. Prof. Dr.Said I.Shalaby, MD,Ph.D. ISSN (Online): 2455-7838
Professor & Vice President
Tropical Medicine, SJIF Impact Factor (2023):8.574
Hepatology & Gastroenterology, NRC, ISI I.F. Value : 1.241
Academy of Scientific Research and Technology,
Cairo, Egypt. DOI : 10.36713/epra2016
2. Dr. Mussie T. Tessema,
Associate Professor,
Department of Business Administration,
Winona State University, MN, EPRA International Journal of
United States of America,
3. Dr. Mengsteab Tesfayohannes,
Associate Professor,
Department of Management,
Research &
Sigmund Weis School of Business,
Susquehanna University,
Selinsgrove, PENN,
Development
United States of America,
4. Dr. Ahmed Sebihi
(IJRD)
Associate Professor
Faculty of General Education,
Monthly Peer Reviewed & Indexed
Skyline University College (SUC), International Online Journal
University City of Sharjah,
UAE.
5. Dr. Anne Maduka, Volume: 9, Issue:1, January 2024
Assistant Professor,
Department of Economics,
Anambra State University, Indexed By:
Igbariam Campus,
Nigeria.
6. Dr. D.K. Awasthi, M.SC., Ph.D.
Associate Professor
Department of Chemistry,
Sri J.N.P.G. College,
Charbagh, Lucknow,
Uttar Pradesh. India
7. Dr. Tirtharaj Bhoi, M.A, Ph.D,
Assistant Professor,
School of Social Science,
University of Jammu,
Jammu, Jammu & Kashmir, India.
8. Dr. Pradeep Kumar Choudhury,
Assistant Professor,
Institute for Studies in Industrial Development,
An ICSSR Research Institute,
New Delhi- 110070, India.
9. Dr. Gyanendra Awasthi, M.Sc., Ph.D., NET
Associate Professor & HOD
Department of Biochemistry,
Dolphin (PG) Institute of Biomedical & Natural
Sciences,
Dehradun, Uttarakhand, India.
10. Dr. C. Satapathy,
Published By
Director,
Amity Humanity Foundation, EPRA Publishing
Amity Business School, Bhubaneswar, CC License
Orissa, India.
11. Dr. Ibatova Shoira Mavlanovna PhD.
Department of Propaedeutics of Paediatric
Diseases, Samarkand State Medical University

,,
SJIF Impact Factor (2023): 8.574| ISI I.F. Value: 1.241| Journal DOI: 10.36713/epra2016 ISSN: 2455-7838(Online)
EPRA International Journal of Research and Development (IJRD)
Volume: 9 | Issue: 1 | January 2024 - Peer Reviewed Journal

EXPLORING AYURVEDIC TREATMENT: A PROMISING APPROACH


FOR AVASCULAR NECROSIS MANAGEMENT

1
Dr. Prasan V. Joshi B.A.M.S., M.D. (Ayu), Dr. Tushar G. Jani*2
B.A.M.S., Dr. Shaik Jeelani Naaz3 B.A.M.S.
1HOD
and Professor, Department of P. G. Studies in Kayachikitsa,
Shri Vijaya Mahantesh Ayurvedic Medical College & P. G. Research Centre, Ilkal, Karnataka, India.
*23rd year P. G. Scholar, Department of P. G. Studies in Kayachikitsa,
Shri Vijaya Mahantesh Ayurvedic Medical College & P. G. Research Centre, Ilkal, Karnataka, India.
33rd year P. G. Scholar, Department of P. G. Studies in Kayachikitsa,

Shri Vijaya Mahantesh Ayurvedic Medical College & P. G. Research Centre, Ilkal, Karnataka, India.

ABSTRACT
Avascular necrosis (AVN) causes bone tissue death due to disrupted blood supply, commonly affecting the hip, knee, and should er
joints. Trauma, prolonged corticosteroid use, alcohol abuse, and specific medical conditions can trigger AVN. Conventional
treatments like medication, physiotherapy, and surgery, although effective, can be expensive with associated side effects. Ayurvedic
medicine, a centuries-old Indian system focusing on holistic well-being and dosha balance, was applied to a 31-year-old male diagnosed
with AVN in the hip joint. Despite no direct AVN - Vatarakta correlation, clinical alignment with Vata Pradhana and Asthi-
Siragata Vata was observed. Treatment involved Ayurvedic medicines, Panchakarma therapies (Virechana, Basti), and lifestyle
adjustments. Following three months of treatment, marked improvements in gait, pain, tenderness, range of movement, and overall
quality of life were reported. This case study suggests that Ayurvedic treatment can serve as a viable alternative to conventional AVN
therapies, especially in cases related to Vatarakta and Asthi-Siragata Vata imbalances. The primary aim of this study is to highlight
Ayurvedic treatment's efficacy in managing AVN.
KEY WORDS: Ayurveda, Treatment, Avascular Necrosis (AVN), Vatarakta, Asthi-Siragata Vata, Panchakarma, Virechana,
Basti.

INTRODUCTION
AVASCULAR NECROSIS (OSTEONECROSIS)
• Avascular Necrosis Overview: Avascular necrosis (osteonecrosis), resulting from ischemia, is a common condition leading to
bone death due to compromised blood supply. Commonly affected areas include the femoral head, humeral head, and femoral
condyles. Its mechanisms vary, from obscure causes to interruptions in bone blood supply induced by trauma, compression, or
thromboembolic obstruction.
• Clinical Presentation and Diagnosis: Symptoms manifest as localized pain worsened by weight-bearing. Diagnosis via MRI
reveals subchondral bone necrosis and bone marrow edema. Early X-rays may appear normal, later showing osteosclerosis and
bone deformities. Long-term consequences can include malignant tumors like osteosarcoma, malignant fibrous histiocytoma,
and fibrosarcoma in affected areas.
• Morphological Features: Pathological fractures occur due to bone infarctions, often at sites with disrupted blood supply in end-
arterial circulation. Grossly, a wedge-shaped infarct is visible in the subchondral bone beneath the joint's convex surface. 1
• Treatment and Management: No specific treatment exists; management focuses on pain control and encouraging mobility.
Interventions such as core decompression alleviate internal bone pressure through drilling and stimulate vascular growth with
implanted devices. Symptoms may spontaneously improve, but joint replacement might be necessary for persistent pain and
significant structural damage.2

➢ Ayurvedic Correlation and Treatment:


This condition aligns with "Vatarakta and Asthi-Siragata Vata" as per Ayurvedic signs and symptoms. Ayurveda offers a wide
range of effective treatment modalities for managing such manifestations.

2024 EPRA IJRD | Journal DOI: https://doi.org/10.36713/epra2016 | https://eprajournals.com/ |50 |


SJIF Impact Factor (2023): 8.574| ISI I.F. Value: 1.241| Journal DOI: 10.36713/epra2016 ISSN: 2455-7838(Online)
EPRA International Journal of Research and Development (IJRD)
Volume: 9 | Issue: 1 | January 2024 - Peer Reviewed Journal

 AVN and Vatarakta


• The disease Vatarakta arises from an abnormal combination of imbalanced Vata and Rakta. The aggravation of Vata and
blood tissue can occur separately, each influenced by their own causative factors. Alternatively, they might be aggravated
by shared factors that affect both Vata and Rakta. In the progression of this condition, both Vata and Rakta can further
exacerbate and influence each other's imbalances.3
• The destruction of bones is attributed to vitiated Vata due to the shared residence and relationship between bones and Vata,
known as Ashraya-Ashrayi Sambandha. This occurs through two pathways:
1. Depletion of tissues exacerbates Vata. When blood tissue diminishes, leading to a loss of blood circulation to the bones
and subsequent bone death, it intensifies Vata imbalance.
2. Aggravated Vata leads to tissue depletion, directly causing the destruction and demise of bone tissue. This imbalanced
Vata also harms blood tissue and disrupts the channels (Srotas) responsible for carrying blood (Raktavaha) and bones
(Asthivaha). The factors causing Vata and blood aggravation, either separately or combined, contribute to the occurrence
of Vatarakta.
• This disease, Vatarakta, similarly affects bones and joints, akin to AVN. Trauma and imbalanced blood are noted among
the causes of Vatarakta, with trauma also recognized as a primary factor in modern medicine for AVN. AVN primarily
affects localized bones and joints, while Vatarakta is said to impact all body joints. Unlike AVN, Ayurveda outlines
premonitory symptoms for Vatarakta, aiding in early disease identification. These symptoms closely resemble the
manifested symptoms of AVN, such as pain (Shula), throbbing sensations (Toda), and constriction of arteries in fingers/toes
and joints, which is a significant factor in AVN development. Severe bone and joint pain (Ati Ruk) are also common
symptoms in both conditions.4 Treatments prescribed for Vatarakta have shown efficacy in alleviating AVN symptoms
and arresting disease progression.

 AVN and Asthi-Siragatavata


• Pathology and presentation of AVN is similar to Asthi and Siragatavata (vitiated Vata dosha affecting the blood vessels
and bones) hence, Asthi and Siragatavata was considered as Ayurvedic diagnosis of the case and the patient was treated on
general lines of management of Vata Vyadhi (various neuromusculoskeletal diseases). Shoola (pain), Aakunchana of Sira
(spasm of vessels) and Puranam of Sira (filling/dilatation of vessels) are also the distinguish features of Siragata Vata.5 It
can be correlated with the Asthigata Vata where the symptoms include Asthikshaya, Asthisoushirya, Balakshaya
(weakness), Shiryantiva Cha Asthinidurbalani (destruction of bony tissue causing generalized weakness) and
Bhedoasthiparvanam (breaking type of pain in bones).6

MATERIALS AND METHODS


• Patient Selection: The patient was selected from the inpatient department of SVM Ayurveda Medical College and RPK
Hospital, Ilkal.
• Study Design: This observational study was a single-arm investigation aimed at assessing the effectiveness of Ayurvedic
treatment for AVN. The study spanned three months, during which the patient received Ayurvedic intervention for AVN.
Informed consent was obtained from the patient in their native language before commencing treatment. The study focuses
on a 31-year-old male patient who displayed signs and symptoms indicative of Vatarakta and Asthi-Siragata Vata (AVN)
for the past eight months, discussed comprehensively.
• Assessment Criteria: Evaluation was based on pre- and post-treatment signs and symptoms. The treatment comprised
Panchakarma (Shodhana) therapy in combination with oral medications (Shamana).

❖ Case Report
• A 31-year-old male, hailing from Gangavathi, Karnataka, presented at the outpatient department (OPD) with primary
complaints of hip joint pain, walking difficulties, and painful internal rotation of the lower limb.

 History of Present Illness


• A previously healthy 31-year-old male, who had a bout of COVID-19 in 2020, subsequently experienced the onset of pain
in his right hip joint after physical activity. The continuous pain extended to both thighs, worsening considerably over eight
months. Seeking relief, he consulted a physician and received allopathic treatments, including steroids, which provided
temporary relief. However, the pain intensified in his left leg over time. Notably, there were no prior instances of diabetes,
hypertension, or metabolic disorders. After six months, an MRI revealed bilateral Femoral Head AVN—Grade III on the
right side and Grade II on the left. Clinical examination showed restricted hip joint movement in flexion, forward bending,
and lateral rotation.
• Following the diagnosis, allopathic doctors recommended surgery, leading to the patient undergoing core decompression.
While experiencing some relief post-surgery for a brief period, he subsequently encountered severe, intermittent pain in
the hip and back regions, affecting his mobility. As the discomfort persisted and expanded to the groin and thigh regions,
2024 EPRA IJRD | Journal DOI: https://doi.org/10.36713/epra2016 | https://eprajournals.com/ |51 |
SJIF Impact Factor (2023): 8.574| ISI I.F. Value: 1.241| Journal DOI: 10.36713/epra2016 ISSN: 2455-7838(Online)
EPRA International Journal of Research and Development (IJRD)
Volume: 9 | Issue: 1 | January 2024 - Peer Reviewed Journal

he sought further assistance at the Kayachikitsa department of RPK Ayurvedic Hospital in Ilkal. Upon evaluation, the
patient was diagnosed with Vatarakta and Asthi-Siragata Vata, classified as subtypes of AVN in Ayurveda.

 General examination
• The patient presented with an average build and exhibited normal vital signs: a pulse rate of 78 beats per minute, a
respiratory rate of 17 breaths per minute, a blood pressure reading of 120/80 mmHg, and a body weight of 73 kg.

 Personal History
• The patient reported a reduced appetite despite being on a mixed diet. Sleep disturbances were noted, and while the
frequency of urination was regular, bowel movements were irregular with unsatisfactory stools. Notably, the patient, a
professor, did not have any addictions or habits.

 Past Medical History


• The patient did not have a known history of major illnesses. However, he was diagnosed with COVID-19 a year and a half
ago and underwent prolonged corticosteroid therapy as part of his treatment. Furthermore, he underwent surgery for AVN,
specifically core decompression, six months prior.

 Ayurvedic Examination:
• The patient underwent examinations of pulse, tongue, and urine, providing additional insights into their dosha imbalances
and overall health condition. The pulse examination indicated an elevation in Vata Dosha, while the examination of the
tongue revealed a coating, suggesting the presence of toxins (Ama).
• Furthermore, the assessment considered the patient's dietary habits and lifestyle elements, including sleep routines, exercise
patterns, and stress levels. These factors were evaluated to understand their potential contributions to Dosha imbalances
and the onset of AVN.

 Ashtasthana Pariksha
SN Pariksha Findings
1 Naadi Vatta – Kapha
2 Mutra 4 to 5 times/day and 1 time/night
3 Mala Constipated and feels unsatisfied.
4 Jihva Liptata (coated)
5 Shabda Prakruta (Normal)
6 Sparsha Anushnasheeta (Normal body temperature)
7 Drik Prakruta (Normal)
8 Akruti Madyama (Moderate)

 Modern Examination
• Local Examination
The physical examination revealed severe and painful limitations in the right hip's range of motion, notably during
abduction and extension. Tenderness and mild temperature elevation were observed upon muscle palpation, while a limp
was evident in the patient's gait. During the straight leg raise test, hip pain emerged alongside thigh discomfort. Lower limb
neurological testing displayed normal reflexes and sensation bilaterally. A surgical scar mark was noted upon inspection,
devoid of swelling or colour changes.

 Investigation
Investigation Observation
X-ray (Both hip joint) No significant Changes
CBC NAD
Urine Routine Microscopic NAD
ECG NAD
MRI of Both Hip Joints Findings are s/o AVN (Avascular necrotic changes) of
B/L femoral heads which was stage - 3 in the right hip and
n left hip Stage - 2
USG(A+P) NAD
Vitamin D 49.62 mg/dl
Calcium 9.9 mg/dl

2024 EPRA IJRD | Journal DOI: https://doi.org/10.36713/epra2016 | https://eprajournals.com/ |52 |


SJIF Impact Factor (2023): 8.574| ISI I.F. Value: 1.241| Journal DOI: 10.36713/epra2016 ISSN: 2455-7838(Online)
EPRA International Journal of Research and Development (IJRD)
Volume: 9 | Issue: 1 | January 2024 - Peer Reviewed Journal

❖ Samprapti (Pathology)
• The inadequate blood supply, known as Avarodha caused by Vata in the Sira, affects the femur's head, leading to depletion
(Sosha) in Sira, Snayu, and Kandara. This depletion weakens the head, neck of the femur, and the hip joint. Additionally,
Vata accumulates in the Rakta (blood) and Asthivaha Srotas (channels related to bones), resulting in the Sosha
(dehydration) of Asthidhatu (bone tissue) due to insufficient nourishment. Furthermore, aggravation of Vata due to
inappropriate dietary choices and lifestyle habits leads to its accumulation in the hip joint, contributing to progressive
degeneration, causing intense pain, and hindering hip joint movement.

❖ Diagnosis- Vatarakta and Asthi-Siragata Vata (Avascular Necrosis).

❖ Treatment
The general principles of management involve initial Snehana (oleation therapy) followed by the treatment of Vatarakta
patients with either Sneha Virechana or Mrudu Rooksha Virechana. Post-purgation, frequent Basti (enema therapy)
comprising both Anuvasana (oil-based) and Niruha (decoction-based) Basti is recommended. Additionally, therapies such
as Seka (pouring of medicated liquids), Abhyanga, Pradeha (medicated pastes), dietary regulation, and appropriate oleation
should be administered, ensuring they do not induce excessive heat (Vidaha).7

➢ Ayurvedic oral medications were prescribed to the patient for Deepana-Pachana (enhancing digestion and metabolism).
The specifics of these medications are outlined below:
S. N. Drug Dose Time Duration
1 Tab Guduchyadi kashaya 2 tabs before food BD 1 week
2 Syp Madiphala rasyana 3 tsf before food BD 1 week
3 Granules freelax 1tsf Empty stomach early 1 week
morning

➢ Posology For Virechana


• The posology for Virechana involved a series of steps:
1. Deepana-Pachana: Initial medication was administered to enhance digestion until suitable Agni Deepana (improved
digestive fire) was achieved.
2. Snehapana: Guduchyadi Ghruta was used in an increasing dosage following Arohana Krama. Starting with 30ml on an
empty stomach, the dosage was gradually increased daily until achieving proper digestion signs (Samyak Snigdha
Lakshana) and then discontinued. This phase typically lasted 4-5 days.
3. Preparation for Virechana: Three days before and on the day of Virechana, Sarvanga Abhyanga (whole body oil
massage) using Ksheerabala Taila was performed, followed by Bashpsweda (steam therapy).
4. Virechana: Gandharva Hastadi Taila was given as Virechana Yoga in the morning, and subjects were observed
throughout the day for signs of successful purgation (Samyak Virechana Lakshana)
5. Samsarjana Karma: Post-purgation, a gradual dietary regimen based on Pravara, Madhyama, and Avara Shuddhi was
followed for proper restoration.

 Basti Karma
➢ Following a 30-day gap, Basti Karma, a therapeutic enema, was administered as per the following protocol:
➢ Details of therapies administered:
S. N. Procedure Ingredients Duration
1 Abhayanga and Sarvanga Seka Ksheerabala Taila 15 days
2 Vashpa Swedana Dashamoola kwatha 15 days
5 Kala Basti 1.Anuvasana basti: 15 days
Mahatiktaka ghrita(100ml) +
Sahacharadi taila(100ml)
2.Niruha basti:
Honey - 60ml
Saindhava - 5 gm
Mahatiktaka ghrita – 100 ml
Satapushpa kalka - 20gm
Mustadi Yapana kwatha - 400 ml

2024 EPRA IJRD | Journal DOI: https://doi.org/10.36713/epra2016 | https://eprajournals.com/ |53 |


SJIF Impact Factor (2023): 8.574| ISI I.F. Value: 1.241| Journal DOI: 10.36713/epra2016 ISSN: 2455-7838(Online)
EPRA International Journal of Research and Development (IJRD)
Volume: 9 | Issue: 1 | January 2024 - Peer Reviewed Journal

 Shamana Aushadhi
➢ The following medications were advised after the completion of the Samsarjana Karma:
S. N. Drug Dose Time Duration
1 Cap Viscovas 1 cap After food TID 2 weeks
2 Cap Bonton 1 cap After food TID 2 weeks
3 Pinda taila + Lin Q.S. Early morning for external 2 weeks
Kineaz application

❖ Observations and Results:


• Radiological exams showed a decrease in the necrotic lesion size in the femoral head, signalling a positive response to
Ayurvedic treatment.
S. N. Symptoms Before Treatment During After Treatment
Treatment
1 Stiffness +++ ++ Nil
2 Tenderness ++ + Nil
3 Pain ++++ +++ +
4 Muscle power Grade 4 Grade 5 Grade 5
5 Raising Of Lower Limbs 30(Degrees) 50 (Degrees) 80 (Degrees)
6 Gait Limping Improving Normal
7 Range of motion Restricted Improving Significantly
improved
➢ Throughout the treatment, no adverse effects were reported, indicating the safety of the Ayurvedic therapy used.
❖ Discussion:
Conventional avascular necrosis (AVN) treatment involves medications, physiotherapy, and surgery to reduce pain,
improve mobility, and prevent bone damage. Severe cases may require joint replacement. In contrast, Ayurvedic medicine
adopts a holistic approach, focusing on harmonizing Vata, Pitta, and Kapha doshas for overall well-being. In AVN,
Ayurveda identifies subtypes—Vatarakta and Asthi-Siragata Vata—stemming from Vata imbalances. Vatarakta causes joint
pain and inflammation, while Asthi-Siragata Vata leads to discomfort and rigidity. Ayurvedic remedies include herbal
formulations, Panchakarma therapies like Abhyanga, Swedana, Virechana, and Basti, along with dietary changes and
exercise.

 Ayurvedic Treatment
➢ Deepana – Pachana
This initial treatment is crucial before any Shodhana Karma as the presence of Ama can hinder the effectiveness of the
purification process. It plays a pivotal role in preparing the body for the primary therapeutic action.
• Tab Guduchyadi Kashaya – It functions as an Agnideepana (boosts digestion), Tridoshashamak (balances Doshas), and a
potent Rasayana (rejuvenating tonic). It possesses antipyretic, anti-inflammatory, antiarthritic, antioxidant, and immune-
modulating properties. This tablet effectively treats various fevers characterized by symptoms like burning sensation,
excessive salivation, thirst, vomiting, and reduced appetite.
• Madiphala Rasayana, an Ayurvedic remedy derived from the wild lemon or Madiphala citrus fruit, serves as a digestive
aid. It effectively alleviates hyperacidity and heartburn. Additionally, Madiphala Rasayana functions as an immunity
booster, enhancing the body's defense mechanisms.
• Freelax granules are effective in treating habitual constipation. It Maintains the elasticity of blood vessels facilitates the
easy removal of stool.

➢ Panchakarma
• Abhyanga (Oleation therapy) – decreases Vata Dosha, promotes Dosha softness, purifies the abdomen (Kostha), enhances
digestive power, and strengthens the body. The Ksheerbala Taila utilized in Abhyanga possesses properties that reduce
Vata, alleviating discomfort (Shula). Its attributes like Snigdha Sukshma enable deep penetration, reducing Vata-related
issues, and effectively combating Vatarakta due to its Tikta and Kashaya Rasa (bitter and astringent taste) properties.
• Swedana (Sudation therapy)– Sweating expels impurities via perspiration, considered a waste (Mala), cleansing the body's
seven tissues (Saptadhatu). Swedana Karma induces intentional perspiration, liquefying accumulated Dosha after
Snehapana. This therapy mobilizes Dosha in subtle channels (Srotas), improving flow. Swedana boosts digestive fire,
increases appetite, clears channels, and reduces lethargy.
• Virechana - Gandharva Hastadi Taila stands out as an effective Sneha Virechana medicine. It aligns Vata, cleanses
channels (Srotovishodhana), enhances strength, addresses lower-body imbalances (Adhobhaga Doshahara), aids digestion,
2024 EPRA IJRD | Journal DOI: https://doi.org/10.36713/epra2016 | https://eprajournals.com/ |54 |
SJIF Impact Factor (2023): 8.574| ISI I.F. Value: 1.241| Journal DOI: 10.36713/epra2016 ISSN: 2455-7838(Online)
EPRA International Journal of Research and Development (IJRD)
Volume: 9 | Issue: 1 | January 2024 - Peer Reviewed Journal

and mitigates swelling (Shothahara). Ideal for Sneha Virechana in Vata disorders involving Rakta/Pitta, like Vataraktha.
Its properties - Teekshna, Sookshma, Sara, Kashaya Rasa, Madhura Vipaka - pacify Vata and Rakta, enabling elimination
of accumulated waste (Sanchita Mala).
• Basti (Enema) - Vatarakta is the Madhyama Rogamarga Vyadhi, finds Basti as its optimal treatment.8 Basti, through
purification, expels excessive deranged metabolic waste, resolving Vata Avarana (obstruction), and reinstating Vyana and
Apana functions. Once purification occurs, digestion normalizes, kickstarting proper metabolism, aiding in the formation
of balanced bodily tissues (Samyak Dhatus).
o Anuvasana Basti: Vata, the primary Dosha and a significant player in disease manifestation (Samprapti), necessitated the
use of Basti therapy for its pacification. Anuvasana Basti utilized Sahacharadi Oil and Guggulu Tiktaka Ghrita. As AVN
affects the Asthi Dhatu (bone tissue), Guggulu Tiktaka Ghrita was chosen due to its indication in Asthi-related disorders.9
Sahacharadi oil properties - Snigdha, Guru, and Ushna Virya—harmonize Vata Dosha, aligning with the treatment goals.
o Niruha Basti: Mustadi Yapana Basti is recommended to enhance strength, vitality (Jeevana Shakti), and fertility (Vrishya).
It effectively addresses inflammation (Shopha), low back pain (Katishoola), discomfort in the calf and thigh areas, and
Vatarakta. This therapy possesses Rasayana qualities, breaking the disease's progression by clearing channel blockages
(Srotoavrodha), purifying channels (Sroto Shodhana), and restoring depleted Dhatus (Kshaya) due to its nourishing
nature.10 Specifically, in AVN of the hip joint, where blockages in small blood vessels cause reduced circulation to the
femoral head, resulting in Raktavaha Srotorodha and subsequent depletion of the bone tissue (Asthi Dhatu), Mustadi
Yapana Basti was administered.

 Shamana Aushadhi
• Cap Bonton - Containing various Ayurvedic herbs like Asthi Shrunkhala, Arjun, Medasak, and Abha Guggulu, is designed
to strengthen bones. It aids in quick fracture healing, boosts calcium deposition at fracture sites, and reduces pain and
inflammation. This supplement enhances bone density in osteoporosis, offering a natural solution for bone health.
• Cap Viscovas - It is formulated to mitigate arterial damage, decrease platelet aggregation, and improve both arterial and
venous circulation. With ingredients like Guggulu, Pippali, Hareetaki, Manjishta, Kulaththa, Shigru, and Paribhadra, it's
beneficial for conditions such as stroke, ischemic heart disease, peripheral vascular disorders, thromboembolism, vascular
headaches, and lipid disorders.
• Pinda Taila - It combines Sariva, Sarjarasa, Manjistha, and Madhuchisstha as herbal pastes (Kalka Dravya). This blend
uses water as a liquid base (Jala) and oil as the oleation medium (Sneha Dravya). These herbs offer sweet, astringent, and
bitter tastes along with cooling properties. They aid in blood purification (Raktaprasadana), pacify Vata and Pitta Doshas
(Vatapittahara), and alleviate swelling (Sothaghna Karma).
• Lin Kineaz - It effectively relieves musculoskeletal pain in various areas such as knee joints, neck, lower back, and
headaches, acting as an analgesic, anti-inflammatory, rubefacient, and desensitizer. Its active constituents penetrate tissues
deeply, inhibiting the release of pain and inflammation-inducing chemical mediators in muscles, joints, and tendons.
➢ Panchakarma therapies may aid in AVN management by offering detoxifying and rejuvenating effects. The combination
of modern medical examinations and Ayurvedic assessments was crucial in diagnosing and managing AVN. While modern
medicine focused on physical and radiological examinations of the necrotic lesion, Ayurveda took a holistic approach,
considering overall health, Dosha imbalances, and lifestyle factors contributing to AVN development. This integration
provides a comprehensive approach to diagnosing and managing various health conditions, including AVN.
❖ Conclusion:
• A blend of Ayurvedic medication and Panchakarma therapies improved joint pain, mobility, and overall well-being in an
AVN patient. This approach notably reduced the necrotic lesion and enhanced hip joint mobility. Ayurveda, particularly in
Vatarakta and Asthi-Siragata Vata cases, shows promise as a safe and effective alternative to standard AVN treatments.
While this study suggests Ayurvedic treatment's potential, larger studies are needed to confirm its effectiveness and safety
in AVN management.

REFERENCES
1. TEXT BOOK OF PATHOLOGY, Harsh Mohan, Jaypee Brothers Medical Publishers (P) Ltd., New Delhi, Edition 7: 2015, section 3,
Chapter 26, Page No 824.
2. Brian R. Walker, Nicki R. Colledge, Stuart H. Ralston, Ian D. Penman (Eds), DAVIDSON’S PRINCIPLES AND PRACTICE OF
MEDICINE, S.H. Ralston, I.B. McInnes, Churchill Livingstone Elsevier, Edition 22, 2014, Chapter 25, Page No 1130.
3. Agnivesha, CHARAKA SAMHITA, Revised by Charaka and Dridhabala, Ayurveda-Dipika Commentary of Chakrapanidatta, Vaidya
Jadavaji Trikamji Acharya, Chaukhambha Orientalia, Varanasi, Reprint Editon: 2015, Chikitsa Sthana, Chapter 29/13-15, Page No
628.
4. Agnivesha, CHARAKA SAMHITA, Revised by Charaka and Dridhabala, Ayurveda-Dipika Commentary of Chakrapanidatta, Vaidya
Jadavaji Trikamji Acharya, Chaukhambha Orientalia, Varanasi, Reprint Editon: 2015, Chikitsa Sthana, Chapter 29/16-18, Page No
628.

2024 EPRA IJRD | Journal DOI: https://doi.org/10.36713/epra2016 | https://eprajournals.com/ |55 |


SJIF Impact Factor (2023): 8.574| ISI I.F. Value: 1.241| Journal DOI: 10.36713/epra2016 ISSN: 2455-7838(Online)
EPRA International Journal of Research and Development (IJRD)
Volume: 9 | Issue: 1 | January 2024 - Peer Reviewed Journal

5. Sushruta, SUSHRUTA SAMHITA, Nibandhasangraha commentary of Sri Dalhanacharya, Vaidya Jadavaji Trikamji Acharya,
Narayan Ram Acharya, Chaukhambha Orientalia, Varanasi, Reprint Editon: 2019, Nidana Sthana, Chapter 1/27, Page No 261.
6. Agnivesha, CHARAKA SAMHITA, Revised by Charaka and Dridhabala, Ayurveda-Dipika Commentary of Chakrapanidatta, Vaidya
Jadavaji Trikamji Acharya, Chaukhambha Orientalia, Varanasi, Reprint Editon: 2015, Chikitsa Sthana, Chapter 28/33, Page No 617.
7. Agnivesha, CHARAKA SAMHITA, Revised by Charaka and Dridhabala, Ayurveda-Dipika Commentary of Chakrapanidatta, Vaidya
Jadavaji Trikamji Acharya, Chaukhambha Orientalia, Varanasi, Reprint Editon: 2015, Chikitsa Sthana, Chapter 29/41-42, Page No
629.
8. Agnivesha, CHARAKA SAMHITA, Revised by Charaka and Dridhabala, Ayurveda-Dipika Commentary of Chakrapanidatta, Vaidya
Jadavaji Trikamji Acharya, Chaukhambha Orientalia, Varanasi, Reprint Editon: 2015, Chikitsa Sthana, Chapter 29/88, Page No 631.
9. Agnivesha, CHARAKA SAMHITA, Revised by Charaka and Dridhabala, Ayurveda-Dipika Commentary of Chakrapanidatta, Vaidya
Jadavaji Trikamji Acharya, Chaukhambha Orientalia, Varanasi, Reprint Editon: 2015, Sutra Sthana, Chapter 28/27, Page No 180.
10. Agnivesha, CHARAKA SAMHITA, Revised by Charaka and Dridhabala, Ayurveda-Dipika Commentary of Chakrapanidatta, Vaidya
Jadavaji Trikamji Acharya, Chaukhambha Orientalia, Varanasi, Reprint Editon: 2015, Siddhi Sthana, Chapter 12/16, Page No 732.

2024 EPRA IJRD | Journal DOI: https://doi.org/10.36713/epra2016 | https://eprajournals.com/ |56 |

You might also like